Reumatoloxía

2008

1. Anti-tumour necrosis factor α therapy modulates ghrelin in patients with severe rheumatoid arthritis

   Annals of the Rheumatic Diseases

2. Autoimmune diseases

   Medicine

3. Budd-Chiari syndrome in a patient with essential thrombocythemia and carrier of G20210A mutation in the prothrombin gene

   Revista Clinica Espanola

4. Cambios entre anti-TNF, ¿están siempre justificados?

   Reumatologia Clinica

5. Carotid intima-media thickness and endothelial function: Useful surrogate markers for establishing cardiovascular risk in patients with inflammatory rheumatic disease

   Arthritis Research and Therapy

6. Endothelial Dysfunction, Carotid Intima-Media Thickness, and Accelerated Atherosclerosis in Rheumatoid Arthritis

   Seminars in Arthritis and Rheumatism

7. Interleukin-6 promoter polymorphism at position - 174 in biopsy-proven patients with erythema nodosum from a defined population

   Clinical and Experimental Rheumatology

8. Polymorphisms in genes encoding tumor necrosis factor-α and HLA-DRB1 are not associated with response to infliximab in patients with rheumatoid arthritis (Journal of Rheumatology (2008) 35, (177-178))

   Journal of Rheumatology

9. Polymorphisms in genes encoding tumor necrosis factor-α and HLA-DRB1 are not associated with response to infliximab in patients with rheumatoid arthritis [1]

   Journal of Rheumatology

10. Repairing erosions in rheumatoid arthritis. A realistic goal

    Rheumatology

11. Reply

    Clinical and Experimental Rheumatology

12. Subclinical atherosclerosis in patients with psoriatic arthritis

    Journal of Rheumatology

13. Sólo lupus: ¡Hazlo!

    Seminarios de la Fundacion Espanola de Reumatologia